Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

EuroIntervention

Volumn 11, Issue 2, 2015, Pages 141-148

  De Ribamar Costa, José ^a   Abizaid, Alexandre ^a   Bartorelli, Antonio L ^b   Whitbourn, Robert ^c   Van Geuns, Robert Jan ^d   Chevalier, Bernard ^e   Perin, Marcos ^f   Seth, Ashok ^g   Botelho, Roberto ^h   Serruys, Patrick W ^d  

^a Instituto de Cardiologia Dante Pazzanese   (Brazil)

^b UNIVERSITY OF MILAN   (Italy)

^c ST VINCENT S HOSPITAL   (Australia)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^g ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^h Instituto Federal Do Triângulo Mineiro   (Brazil)

Author keywords

Bioresorbable scaffold; Coronary artery disease; Percutaneous coronary intervention; Post dilation

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; BIORESORBABLE SCAFFOLD; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; IN-SCAFFOLD STENOSIS; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PROGNOSIS; SCAFFOLD THROMBOSIS; STENT THROMBOSIS; ADVERSE EFFECTS; AGED; BIODEGRADABLE IMPLANT; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

CARDIOVASCULAR AGENT;

ABSORBABLE IMPLANTS; AGED; CARDIOVASCULAR AGENTS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84979798539     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY15M05_06     Document Type: Article

References (15)

1. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-88.
2. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG; POST Registry Investigators. Predictors and outcomes of stent thrombosis: an intravascular ultra-sound registry. Eur Heart J. 2002;23:124-32.
3. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, Moussa I, Dangas G, Mehran R, Lansky AJ, Reyes A, Kreps E, Collins M, Colombo A, Stone GW, Teirstein PS, Leon MB, Moses JW. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation. 2004;109:1085-8.
4. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ; SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43:1959-63.
5. Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2014;83:873-8.
6. Armstrong EJ, Kwa AT, Yeo KK, Mahmud E, Javed U, Patel M, Shunk KA, MacGregor JS, Low RI, Rogers JH. Angiographically confirmed stent thrombosis in contemporary practice: insights from intravascular ultrasound. Catheter Cardiovasc Interv. 2013;81:782-90.
7. Abizaid A, Costa JR Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10: 1396-401.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.
9. Onuma Y, Serruys PW, Gomez J, de Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Garcia-Garcia H, Ormiston JA; ABSORB Cohort A and B investigators. Comparison of in vivo acute stent recoil between the bioresorbable everolimuseluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent. Catheter Cardiovasc Interv. 2011;78:3-12.
10. Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2015;10:1144-53.
11. Dirschinger J, Kastrati A, Neumann FJ, Boekstegers P, Elezi S, Mehilli J, Schühlen H, Pache J, Alt E, Blasini R, Steinbeck G, Schömig A. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. Circulation. 1999;100:918-23.
12. Farooq V, Vranckx P, Mauri L, Cutlip DE, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Negoita M, van Leeuwen F, Neumann FJ, Yeung AC, Garcia-Garcia HM, Serruys PW. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart. 2013;9:626-33.
13. Kitabata H, Loh JP, Pendyala LK, Badr S, Dvir D, Barbash IM, Minha S, Torguson R, Chen F, Satler LF, Suddath WO, Kent KM, Pichard AD, Waksman R. Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents. Am J Cardiol. 2013;112:1093-8.
14. Ruchin PE, Trabattoni D, Fabbiocchi F, Montorsi P, Lualdi A, Ravagnani P, Grancini L, Galli S, Teruzzi G, Calligaris G, De Martini S, Bartorelli AL. Use of multiple overlapping sirolimuseluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients. Int J Cardiol. 2009;134:231-7.
15. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE, Diletti R, Radu MD, Räber L, Bourantas CV, Zhang Y, van Remortel E, Pawar R, Rapoza RJ, Powers JC, van Beusekom HM, Garcìa-Garcìa HM, Virmani R. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. JACC Cardiovasc Interv. 2013;6:523-32.